Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 8/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.62 |
| ▸ | MEN1 | O00255 | 3/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.62 |
| ▸ | POLB | P06746 | 2/20 | 0.62 |
| ▸ | TSHR | P16473 | 2/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.62 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.50 |
| ▸ | MPI | P34949 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9378154 | 0.95 | MAPT (0.58) | MAPTTDP1ALDH1A1MEN1KMT2A | |
| SCHEMBL19511923 | 0.94 | MAPT (0.62) | MAPTTDP1ALDH1A1MEN1KMT2A | |
| SCHEMBL3243151 | 0.92 | MAPT (0.60) | MAPTTDP1ALDH1A1MEN1KMT2A | |
| Pyrazine SCHEMBL27720028 | 0.88 | MAPT (0.52) | MAPTTDP1ALDH1A1MEN1KMT2A | |
| SCHEMBL3975452 | 0.87 | MAPT (0.56) | MAPTTDP1ALDH1A1MEN1KMT2A | |
| SCHEMBL10488867 | 0.86 | TSHR (0.57) | MAPTTDP1ALDH1A1MEN1KMT2A | |
| SCHEMBL8406658 | 0.86 | MAPT (0.57) | MAPTTDP1ALDH1A1MEN1KMT2A | |
| SCHEMBL13609636 | 0.86 | ALDH1A1 (0.52) | MAPTTDP1ALDH1A1MEN1KMT2A | |
| Bromide SCHEMBL4266547 | 0.84 | ALDH1A1 (0.50) | MAPTTDP1ALDH1A1MEN1KMT2A | |
| SCHEMBL7653551 | 0.83 | ALDH1A1 (0.53) | MAPTTDP1ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114940780-B | Tetra-amide nucleating agent and polypropylene composition | 朴蓝聚烯烃科技发展（上海）有限公司 | 2023-06-30 | — | — | CN | claimed |
| CN-114940652-A | Tetraaminobenzene derivative and preparation method thereof | 朴蓝聚烯烃科技发展（上海）有限公司 | 2022-08-26 | — | — | CN | claimed |
| US-8158830-B1 | Integrated process for the preparation of tetraaminobenzene | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-04-17 | — | — | US | claimed |
| US-8143450-B1 | Process for the preparation of derivatives of tetraaminobenzene | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-03-27 | — | — | US | claimed |
| US-8071812-B1 | Process for the synthesis of 1,3-diamino-4,6-dinitrobenzene | E.I DU PONT DE NEMOURS & COMPANY (US) | 2011-12-06 | — | — | US | claimed |
| EP-3238815-B1 | COMPOSITE SEMIPERMEABLE MEMBRANE | TORAY INDUSTRIES (JP) | 2026-01-28 | — | — | EP | disclosed |
| CN-119771398-A | Catalyst, preparation method thereof and application thereof in synthesis of 2,3, 6-triamino-5-nitropyridine | 中国石油化工股份有限公司 | 2025-04-08 | — | — | CN | disclosed |
| CN-118878536-B | Pyrrolo [4,3,2-de ] quinoline derivative | 齐鲁师范学院 | 2025-01-03 | — | — | CN | disclosed |
| CN-118878536-A | Pyrrolo [4,3,2-de ] quinoline derivative | 齐鲁师范学院 | 2024-11-01 | — | — | CN | disclosed |
| CN-118063325-A | Method for synthesizing 1,2,4, 5-tetraaminobenzene hydrochloride | 常州大学 | 2024-05-24 | — | — | CN | disclosed |
| CN-116666897-A | Diaphragm material for battery | 朴烯晶新能源材料(上海)有限公司 | 2023-08-29 | — | — | CN | disclosed |
| CN-114940780-B | Tetra-amide nucleating agent and polypropylene composition | 朴蓝聚烯烃科技发展（上海）有限公司 | 2023-06-30 | — | — | CN | disclosed |
| WO-2011084810-A2 | 2,4,5-TRIAMINOPHENOLS AND RELATED COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-07-14 | — | — | WO | disclosed |
| WO-2011084762-A2 | 2,4,5-TRIAMINOPHENOLS AND RELATED COMPOUNDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-07-14 | — | — | WO | disclosed |
| US-20100160686-A1 | Process for the Preparation of Monomers for Polybenzimidazole Materials | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-06-24 | — | — | US | disclosed |
| US-20090137814-A1 | Synthesis of diaminodinitropyridine | DUPONT SAFETY & CONSTRUCTION, INC. | 2009-05-28 | — | — | US | disclosed |
| US-5811492-A | HAVING EXCELLENT HEAT, FIRE, CHEMICAL AND IMPACT RESISTANCE, MECHANICAL STRENGTH, AND MOLDABILITY; CONTAINING AMINO GROUPS, HYDROGENATED BLOCK COPOLYMER AND A POLYAMIDE RESIN | GENERAL ELECTRIC COMPANY (US) | 1998-09-22 | — | — | US | disclosed |
| US-4954638-A | ANTIALLERGENS, ANTIINFLAMMATORY | MERCK FROSST CANADA, INC. (CA) | 1990-09-04 | — | — | US | disclosed |
| US-4767745-A | 1,5-DIFLUORO-2,4-DINITRO BENZENE AND 6-N-MALEIMIDOHEXANOIC ACID CHLORIDE AS COUPLING AGENTS; ANTIALLERGENS, ANTIINFLAMMATORY AGENTS | MERCK FROSST CANADA, INC. (CA) | 1988-08-30 | — | — | US | disclosed |
| EP-0179959-A1 | Conjugates of leukotrienes with proteins | MERCK FROSST CANADA INC. (CA) | 1986-05-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100160686-A1 | Process for the Preparation of Monomers for Polybenzimidazole Materials | PBRM1, PUF60, PARG | MAPT 518/4885TDP1 1642/4885ALDH1A1 2542/4885 |
| US-20090137814-A1 | Synthesis of diaminodinitropyridine | ODC1, NOS1, SRM | MAPT 1779/4885TDP1 1292/4885ALDH1A1 1867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.